001     910174
005     20221209131503.0
037 _ _ |a FZJ-2022-03654
041 _ _ |a English
100 1 _ |a Ermert, Johannes
|0 P:(DE-Juel1)131818
|b 0
|e Corresponding author
|u fzj
111 2 _ |a DPhG Annual Meeting 2022
|g DPhG 2022
|c Marburg
|d 2022-09-14 - 2022-09-16
|w Germany
245 _ _ |a Radiosynthesis and biological evaluation of [18F]R91150, a selective 5-HT2A receptor antagonistfor PET imaging
260 _ _ |c 2022
336 7 _ |a Conference Paper
|0 33
|2 EndNote
336 7 _ |a Other
|2 DataCite
336 7 _ |a INPROCEEDINGS
|2 BibTeX
336 7 _ |a conferenceObject
|2 DRIVER
336 7 _ |a LECTURE_SPEECH
|2 ORCID
336 7 _ |a Conference Presentation
|b conf
|m conf
|0 PUB:(DE-HGF)6
|s 1670586993_28873
|2 PUB:(DE-HGF)
|x Invited
520 _ _ |a Serotonergic 5-HT2A receptors (5-HT2ARs) in cortical and forebrain regions are an important substrate for theneuromodulatory actions of serotonin in the brain. They have been implicated in the etiology of manyneuropsychiatric disorders and serve as a target for (novel) antipsychotic, antidepressant and anxiolytic drugs.Positron emission tomography (PET) imaging using suitable radioligands can be applied for in vivo quantificationof (alterations in) receptor densities and receptor occupancy for therapy evaluation [1]. The original radiosynthesisof the selective 5-HT2AR antagonist [18F]R91150 was performed in six steps, which is laborious, time-consuming,and has low RCYs of <5%, preventing widespread use of this radioligand [2]. In this work, [18F]R91150 wasprepared using late-stage Cu-mediated radiofluorination of a corresponding NBoc-protected boronic acid pinacoleester to simplify and accelerate synthesis of the radioligand. Boc-protected [18F]R91150 was prepared in a yield of10-15% (non-decay-corrected (n.d.c.), determined by radio-HPLC, n=3) within 10 min and isolated by SPE (C18cartridge). Deprotection by TFA at 80 °C for 5 min succeeded quantitatively. Isolation by analytical radio-HPLCafforded the desired 5-HT2A-radioligand [18F]R91150 in a yield of 10% (n.d.c.) after 60 min. Autoradiographicexamination of [18F]R91150 revealed discrete accumulation in specific brain areas, that was entirely replaceable bynon-radioactive R91150, altanserin and (+)-lisuride. As expected, the less 5-HT2A specific (-)-lisuride could notcompletely compete with the binding of [18F]R91150. The in-vitro evaluation of [18F]R91150 revealed the potentialof this tracer for PET imaging of 5-HT2AR status in the human brain [3]. Future studies will focus on the in vivobehaviour of [18F]R91150 and the transfer of its synthesis to an automated module for clinical applications.
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
700 1 _ |a Willmann, Michael
|0 P:(DE-Juel1)173964
|b 1
700 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 2
|u fzj
856 4 _ |u https://juser.fz-juelich.de/record/910174/files/Abstract-Vorlage%20DPhG%20Ermert.pdf
|y Restricted
856 4 _ |u https://juser.fz-juelich.de/record/910174/files/acsmedchemlett.0c00658.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:910174
|p VDB
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)131818
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)166419
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
914 1 _ |y 2022
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a conf
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21